Medicx Fund Regulatory News (MXF)

1. ORDINARY RESOLUTION

IT WAS RESOLVED to re-appoint KPMG LLP as auditors of the Company.

In Favour - 152,953,560 (99.99%)

Against - 9,330 (0.01%)

Withheld - Nil

2. ORDINARY RESOLUTION

IT WAS RESOLVED to authorise the Directors to determine the remuneration of the auditors.

In Favour - 152,957,160 (99.99%)

Against - 5,730 (0.01%)

Withheld - Nil

3. ORDINARY RESOLUTION

IT WAS RESOLVED to approve the Annual Report and the Audited Financial Statements of the Company for the year ended 30 September 2016.

In Favour - 152,962,890 (100.00%)

Against - Nil

Withheld - Nil

4. ORDINARY RESOLUTION

IT WAS RESOLVED to approve the dividend policy of the Company.

In Favour - 152,962,890 (100.00%)

Against - Nil

Withheld - Nil

5. ORDINARY RESOLUTION

IT WAS RESOLVED to approve the Directors' Remuneration Report for the year ended 30 September 2016.

In Favour - 152,944,430 (99.99%)

Against - 15,600 (0.01%)

Withheld - 2,860

6. ORDINARY RESOLUTION

IT WAS RESOLVED to re-appoint Shelagh Mason as a Director of the Company.

In Favour - 150,902,163 (99.99%)

Against - 1,730 (0.01%)

Withheld - 2,058,997

7. ORDINARY RESOLUTION

IT WAS RESOLVED to re-appoint John Hearle as a Director of the Company.

In Favour - 150,903,893 (100.00%)

Against - Nil

Withheld - 2,058,997

8. ORDINARY RESOLUTION

IT WAS RESOLVED to re-appoint Stephen Le Page as a Director of the Company.

In Favour - 152,960,030 (99.99%)

Against - 1,730 (0.01%)

Withheld - 1,130

9. ORDINARY RESOLUTION

IT WAS RESOLVED to re-appoint David Staples as a Director of the Company.

In Favour - 152,961,760 (100.00%)

Against - Nil

Withheld - 1,130

10. SPECIAL RESOLUTION

IT WAS RESOLVED to renew the authority set out in Article 4.2 of the Articles of Incorporation of the Company for a further period up to the conclusion of the next annual general meeting of the Company so that (without prejudice to the authority conferred on the Directors pursuant to Article 4) the Directors are generally and unconditionally authorised in substitution for all existing authorities to exercise all powers of the Company to issue, grant rights to subscribe for, or to convert any securities into, shares in the Company ("equity securities"):

 (a) up to an amount of 132,322,281 shares; and

 (b) up to a further amounts of 132,322,281 shares in connection with an offer by way of a rights issue in favour of holders of equity securities where the equity securities respectively attributable to the interests of all holders of equity securities are proportionate (as nearly as may be practicable) to the respective numbers of equity securities held by them,

which authority shall expire at the conclusion of the next annual general meeting of the Company to be held after the passing of this resolution (unless previously renewed, revoked or varied by the Company in general meeting), except that the Company may make an offer or agreement before such expiry, which would or might require the issue of equity securities after such expiry, and the Directors may issue equity securities in pursuance of any such offer or agreement as if the authority in question had not expired.

In Favour - 152,951,270 (99.99%)

Against - 11,620 (0.01%)

Withheld - Nil

11. SPECIAL RESOLUTION

IT WAS RESOLVED, that the Company be generally and unconditionally authorised to make market acquisitions of its own shares (within the meaning of Section 315 of The Companies (Guernsey) Law, 2008, as amended) and the Company be generally and unconditionally authorised to hold the maximum number permitted by section 327 of The Companies (Guernsey) Law, 2008, as amended, of such shares so purchased as treasury shares provided that:

(a) the maximum number of ordinary shares authorised to be acquired is such number representing 14.99 per cent. of the issued share capital of the Company (rounded to the nearest whole number);

(b) the minimum price that may be paid for each ordinary share is one penny;

(c) the maximum price that may be paid for each ordinary share is an amount equal to the higher of: (i) 105 per cent. of the average of the middle market quotations for a share as derived from the Daily Official List of the London Stock Exchange for the five Business Days immediately preceding the day on which that share is purchased; (ii) the price of the last independent trade; and (iii) the highest current independent bid at the time of purchase;

(d) any purchase of ordinary shares shall be made in the market for cash at prices below the prevailing net asset value per share (as determined by the Directors);

(e) the authority conferred shall expire at the conclusion of the next annual general meeting of the Company to be held in 2018, unless such authority is renewed prior to such time; and

(f) the Company may, before such expiry, make an offer or agreement which would or might require shares to be repurchased after such expiry and the Company may repurchase shares in pursuance of such an offer or agreement as if the authority conferred hereby had not expired.

In Favour - 152,910,418 (99.97%)

Against - 52,472 (0.03%)

Withheld - Nil

12. SPECIAL RESOLUTION

IT WAS RESOLVED that, subject to the passing of Resolution 10, and in accordance with Article 13.5, Article 13.3 shall be excluded to the extent necessary to provide the Directors with authority to issue equity securities for cash (including, without limitation, the authority to sell equity securities in the form of ordinary shares that immediately before sale were held by the Company as treasury shares) pursuant to the authority conferred by Resolution 10, such power to be limited:

(a) to the issue of equity securities in connection with a rights issue in favour of holders of equity securities where the equity securities respectively attributable to the interests of all holders of equity securities are proportionate (as nearly as may be practicable) to the respective numbers of equity securities held by them; and

(b) to the issue (otherwise than under paragraph (a) above) of equity securities on a non-pre-emptive basis up to an amount representing 10 per cent. of the issued share capital of the Company (excluding treasury shares) from time to time, provided that such equity securities are issued at a price not less than the Company's EPRA

net asset value per share at the time of the issue,

provided that this authority shall expire at the conclusion of the Company's next annual general meeting to be held in 2018 after the passing of this resolution (unless previously renewed, revoked or varied by the Company in general meeting) except that the Company may make an offer or agreement as contemplated by paragraph (a) or (b) of this resolution before the expiry of the relevant authority, which would or might require the issue of equity securities after such expiry, and the Directors may issue equity securities in pursuance of any such offer or agreement as if the authority in question had not expired.

In Favour - 152,948,580 (99.99%)

Against - 9,580 (0.01%)

Withheld - 4,730

13. SPECIAL RESOLUTION

IT WAS RESOLVED that, the articles of incorporation marked 'A' and tabled at the meeting be adopted as the new Articles of Incorporation of the Company in substitution for the existing Articles of Incorporation.

In Favour - 152,765,318 (99.94%)

Against - 91,444 (0.06%)

Withheld - 106,128